Ladenburg Thalmann Initiates Coverage On Coeptis Therapeutics With Buy Rating, Announces Price Target of $3
Ladenburg Thalmann Initiates Coverage On Coeptis Therapeutics With Buy Rating, Announces Price Target of $3
Ladenburg Thalmann 以買入評級開始對Coeptis Therapeutics進行報道,宣佈目標股價爲3美元
Ladenburg Thalmann analyst Aydin Huseynov initiates coverage on Coeptis Therapeutics (NASDAQ:COEP) with a Buy rating and announces Price Target of $3.
拉登堡·塔爾曼分析師Aydin Huseynov以買入評級啟動對Coeptis治療公司(納斯達克:COEP)的報道,並宣佈目標價為3美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。